These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11267185)

  • 1. ISA(TX)247: a novel calcineurin inhibitor.
    Aspeslet L; Freitag D; Trepanier D; Abel M; Naicker S; Kneteman N; Foster R; Yatscoff R
    Transplant Proc; 2001; 33(1-2):1048-51. PubMed ID: 11267185
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates.
    Stalder M; Bîrsan T; Hubble RW; Paniagua RT; Morris RE
    J Heart Lung Transplant; 2003 Dec; 22(12):1343-52. PubMed ID: 14672749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitors and cardiac hypertrophy.
    Force T; Rosenzweig A; Choukroun G; Hajjar R
    Lancet; 1999 Apr; 353(9161):1290-2. PubMed ID: 10218524
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment.
    Zehngawa W
    Eur J Clin Pharmacol; 2005 Jun; 61(4):317. PubMed ID: 15891875
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.
    Kim H; Csaky KG; Gilger BC; Dunn JP; Lee SS; Tremblay M; de Monasterio F; Tansey G; Yuan P; Bungay PM; Lutz RJ; Robinson MR
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):655-62. PubMed ID: 15671296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of genetic polymorphism on disposition of calcineurin inhibitors in solid organ transplantation].
    Li D; Zhu L; Ye Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):1018-22. PubMed ID: 20871172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitors and cardiac hypertrophy.
    Luo Z; Shyu KG; Gualberto A; Walsh K
    Nat Med; 1998 Oct; 4(10):1092-3. PubMed ID: 9771723
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens.
    Blankenship JR; Singh N; Alexander BD; Heitman J
    J Clin Microbiol; 2005 Jan; 43(1):464-7. PubMed ID: 15635017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication.
    Wynn C; Pan F; Erickson L; Ebbs A; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1387-9. PubMed ID: 12176408
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity.
    Fukudo M; Yano I; Masuda S; Okuda M; Inui K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):816-25. PubMed ID: 15383634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex.
    Phillis JW; Diaz FG; O'Regan MH; Pilitsis JG
    Brain Res; 2002 Dec; 957(1):12-24. PubMed ID: 12443975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs.
    Dahmen U; Gu Y; Shen K; Dirsch O; Li J; Fan L; Broelsch C
    Transplant Proc; 2002 Sep; 34(6):2312-3. PubMed ID: 12270412
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics.
    Oellerich M; Barten MJ; Armstrong VW
    Ther Drug Monit; 2006 Feb; 28(1):35-8. PubMed ID: 16418691
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
    Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the inhibition of IL-2 production by calcineurin inhibitors.
    van den Berg AP; van Son WJ; Haagsma EB; The TH; Slooff MJ; de Leij LM
    Transplant Proc; 2001; 33(1-2):1076-7. PubMed ID: 11267197
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
    Lim HW; De Windt LJ; Steinberg L; Taigen T; Witt SA; Kimball TR; Molkentin JD
    Circulation; 2000 May; 101(20):2431-7. PubMed ID: 10821822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclosporine and some derivatives on chronic rejection.
    Lu X; Dawson J; Borel JF
    Transplant Proc; 1996 Dec; 28(6):3152-3. PubMed ID: 8962221
    [No Abstract]   [Full Text] [Related]  

  • 19. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
    Flechner SM; Goldfarb D; Modlin C; Feng J; Krishnamurthi V; Mastroianni B; Savas K; Cook DJ; Novick AC
    Transplantation; 2002 Oct; 74(8):1070-6. PubMed ID: 12438948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.